loading

Finanzdaten der Scribe Therapeutics Inc. Common Stock-Aktie (SCTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30
Periodenlänge 3 Monate
Revenues
Operating Expenses
Operating Income/Loss
Nonoperating Income/Loss
Income/Loss From Continuing Operations Before Tax
Income Tax Expense/Benefit
Net Income/Loss
Basic Average Shares
Diluted Average Shares
Basic Earnings Per Share
Diluted Earnings Per Share
$8.80
price down icon 1.46%
$19.69
price down icon 6.77%
$7.36
price down icon 5.88%
WVE WVE
$3.28
price down icon 5.20%
$3.61
price down icon 9.52%
$14.59
price down icon 9.99%
Kapitalisierung:     |  Volumen (24h):